Imaging Approaches for Dementia

Research output: Contribution to journalLiterature review

9 Citations (Scopus)

Abstract

Brain imaging has progressed from exclusion of rare treatable mass lesions to a specific antemortem diagnosis. MR imaging-derived hippocampal atrophy and WMH are regarded as imaging biomarkers of AD and CVD respectively. Abnormal FP-CIT SPECT or cardiac iodobenzamide SPECT is a useful supportive imaging feature in the diagnosis of DLB. Frontal and/or anterior temporal atrophy and anterior defects on molecular imaging with FDG-PET or perfusion SPECT are characteristic of FTDs. Whole-body FDG-PET may be helpful in patients with rapidly progressing “autoimmune dementias,” and FLAIR and DWI are indicated in suspected CJD. A major role of imaging is in the development of new drugs and less costly biomarkers.
Original languageEnglish
Pages (from-to)1836-1844
Number of pages9
JournalAmerican Journal of Neuroradiology
Volume33
Issue number11
Early online date1 Dec 2011
DOIs
Publication statusPublished - Nov 2012

Fingerprint

Single-Photon Emission-Computed Tomography
Dementia
Atrophy
Biomarkers
Molecular Imaging
Neuroimaging
Perfusion
Pharmaceutical Preparations

Cite this

Imaging Approaches for Dementia. / Murray, Alison Dorothy.

In: American Journal of Neuroradiology, Vol. 33, No. 11, 11.2012, p. 1836-1844.

Research output: Contribution to journalLiterature review

@article{3e53ff3c21d348208efcc75a3eeb00e5,
title = "Imaging Approaches for Dementia",
abstract = "Brain imaging has progressed from exclusion of rare treatable mass lesions to a specific antemortem diagnosis. MR imaging-derived hippocampal atrophy and WMH are regarded as imaging biomarkers of AD and CVD respectively. Abnormal FP-CIT SPECT or cardiac iodobenzamide SPECT is a useful supportive imaging feature in the diagnosis of DLB. Frontal and/or anterior temporal atrophy and anterior defects on molecular imaging with FDG-PET or perfusion SPECT are characteristic of FTDs. Whole-body FDG-PET may be helpful in patients with rapidly progressing “autoimmune dementias,” and FLAIR and DWI are indicated in suspected CJD. A major role of imaging is in the development of new drugs and less costly biomarkers.",
author = "Murray, {Alison Dorothy}",
year = "2012",
month = "11",
doi = "10.3174/ajnr.A2782",
language = "English",
volume = "33",
pages = "1836--1844",
journal = "American Journal of Neuroradiology",
issn = "0195-6108",
publisher = "American Society of Neuroradiology",
number = "11",

}

TY - JOUR

T1 - Imaging Approaches for Dementia

AU - Murray, Alison Dorothy

PY - 2012/11

Y1 - 2012/11

N2 - Brain imaging has progressed from exclusion of rare treatable mass lesions to a specific antemortem diagnosis. MR imaging-derived hippocampal atrophy and WMH are regarded as imaging biomarkers of AD and CVD respectively. Abnormal FP-CIT SPECT or cardiac iodobenzamide SPECT is a useful supportive imaging feature in the diagnosis of DLB. Frontal and/or anterior temporal atrophy and anterior defects on molecular imaging with FDG-PET or perfusion SPECT are characteristic of FTDs. Whole-body FDG-PET may be helpful in patients with rapidly progressing “autoimmune dementias,” and FLAIR and DWI are indicated in suspected CJD. A major role of imaging is in the development of new drugs and less costly biomarkers.

AB - Brain imaging has progressed from exclusion of rare treatable mass lesions to a specific antemortem diagnosis. MR imaging-derived hippocampal atrophy and WMH are regarded as imaging biomarkers of AD and CVD respectively. Abnormal FP-CIT SPECT or cardiac iodobenzamide SPECT is a useful supportive imaging feature in the diagnosis of DLB. Frontal and/or anterior temporal atrophy and anterior defects on molecular imaging with FDG-PET or perfusion SPECT are characteristic of FTDs. Whole-body FDG-PET may be helpful in patients with rapidly progressing “autoimmune dementias,” and FLAIR and DWI are indicated in suspected CJD. A major role of imaging is in the development of new drugs and less costly biomarkers.

U2 - 10.3174/ajnr.A2782

DO - 10.3174/ajnr.A2782

M3 - Literature review

VL - 33

SP - 1836

EP - 1844

JO - American Journal of Neuroradiology

JF - American Journal of Neuroradiology

SN - 0195-6108

IS - 11

ER -